Skip to content
Clinical Trials – home
PortugalBack to Portugal

Clinical trials in Guilhufe – page 32

694 clinical trials in Guilhufe, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

PortugalOur site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Guilhufe at a glance
694
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

694 trials in Guilhufe

Open in trial search

Polyneuropathy

Not recruiting

A study to evaluate the safety and effectiveness of nucresiran and vutrisiran in patients with hereditary transthyretin amyloidosis with polyneuropathy

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Nucresiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Asociacion Grupo Tratamiento De Tumores Digestivos
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Cytisinicline
  • Sponsor:Achieve Life Sciences Inc.
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Nicorandil
  • Sponsor:Auxilius Pharma Sp. z o.o.
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Ruxolitinib
  • Sponsor:Bluepharma Industria Farmaceutica S.A.

Single‑dose Bioavailability of Gliclazide Modified‑Release Tablets in Healthy Volunteers (Type 2 Diabetes)

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Gliclazide
  • Sponsor:Institut De Recherches Internationales Servier IRIS
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Empagliflozin
  • Sponsor:Tecnimede-Sociedade Tecnico-Medicinal S.A.
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Apixaban
  • Sponsor:Laboratorios Cinfa S.A.
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Tofacitinib
  • Sponsor:Bluepharma Industria Farmaceutica S.A.

Evaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies

InvestigationalNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · 65+ years
  • Substances:Nemtabrutinib
  • Sponsor:Merck Sharp & Dohme LLC
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Ulipristal Acetate
  • Sponsor:Laboratorios Leon Farma S.A.

Schizophrenia

Not recruiting

Relative Bioavailability of LY03010 versus Paliperidone Palmitate (with Risperidone background) in Healthy Volunteers for Schizophrenia

Registered drugNo placebo
Countries:PortugalPortugal
  • Participants:18–64 years · Healthy volunteers
  • Substances:Risperidone
  • Sponsor:Geneora Pharma (Shijiazhuang) Co. Ltd.

Other cities in Portugal

The busiest research cities in the country

All 48 cities in Portugal

Clinical research in Guilhufe

What the registry says about research in the country

01 Autoimmune Disorders

Innovative research focusing on Systemic Lupus Erythematosus (SLE) treatment evaluation, examining new therapeutic approaches for patients with moderate to severe manifestations of the disease.

  • Disease management strategies
  • Long-term safety assessment
  • Treatment efficacy evaluation

Studies aim to advance understanding of treatment responses in adults with active SLE despite ongoing therapy.

02 Cardiovascular Medicine

Advanced clinical research investigating stroke prevention in patients with atrial fibrillation, comparing innovative anticoagulation approaches.

  • Stroke prevention strategies
  • Bleeding risk assessment
  • Systemic embolism prevention

Comparative studies evaluating treatment efficacy and safety profiles in cardiac patients.

03 Infectious Diseases

Observational research examining mpox virus disease outcomes and treatment effectiveness, with particular focus on antiviral interventions.

  • Clinical outcome analysis
  • Antiviral treatment evaluation
  • Disease progression monitoring

Research aims to enhance understanding of treatment responses in infected patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.